Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Korsana Biosciences Inc. market cap is $1.61B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Korsana Biosciences Inc. 52 week high is $59.36 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Korsana Biosciences Inc. 52 week low is $7.19 as of November 21, 2026.
Korsana Biosciences Inc. stock price today is $37.56.
Korsana Biosciences Inc. stock price yesterday was $35.45.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Korsana Biosciences Inc.'s P/E ratio is -2.87.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Korsana Biosciences Inc. P/B ratio is 4.3685.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Korsana Biosciences Inc. 50-day moving average is $32.30.